• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Exp Ther Med . Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-

tetano

Editor, Senior Moderator
Exp Ther Med


. 2022 Jun;23(6):418.
doi: 10.3892/etm.2022.11345. Epub 2022 Apr 29.
Differential impact of the angiotensin-converting enzyme-2 (ACE2 rs4343 G>A) and miR-196a2 rs11614913 C>T gene alterations in COVID-19 disease severity and mortality


Mohammad Muzaffar Mir[SUP] 1 [/SUP], Rashid Mir[SUP] 2 [/SUP], Mushabab Ayed Abdullah Alghamdi[SUP] 3 [/SUP], Badr Abdulmohsin Alsayed[SUP] 4 [/SUP], Imadeldin Elfaki[SUP] 5 [/SUP], Ali Al Bshabshe[SUP] 6 [/SUP], Rabia Farooq[SUP] 1 [/SUP], Muhanad Alhujaily[SUP] 7 [/SUP], Muffarah Hamid Alharthi[SUP] 8 [/SUP], Mohannad Mohammad S Alamri[SUP] 8 [/SUP], Abdullah M Al-Shahrani[SUP] 8 [/SUP]



Affiliations

Abstract

The recent coronavirus outbreak from Wuhan China in late 2019 caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) resulted in a global pandemic of coronavirus-19 disease (COVID-19). Understating the underlying mechanism of the pathogenesis of coronavirus infection is important not only because it will help in accurate diagnosis and treatment of the infection but also in the production of effective vaccines. The infection begins when SARS-CoV-2 enters the cells through binding of its envelope glycoprotein to angiotensin-converting enzyme2 (ACE2). Gene variations of ACE2 and microRNA (miR)-196 are associated with viral infection and other diseases. The present study investigated the association of the ACE2 rs4343 G>A and miR-196a2 rs11614913 C>T gene polymorphisms with severity and mortality of COVID-19 using amplification refractory mutation system PCR in 117 COVID-19 patients and 103 healthy controls from three regions of Saudi Arabia. The results showed that ACE2 rs4343 GA genotype was associated with severity of COVID-19 (OR=2.10, P-value 0.0028) and ACE2 rs4343 GA was associated with increased mortality with OR=3.44, P-value 0.0028. A strong correlation between the ACE2 rs4343 G>A genotype distribution among COVID-19 patients was reported with respect to their comorbid conditions including sex (P<0.023), coronary artery disease (P<0.0001), oxygen saturation <60 mm Hg (P<0.0009) and antiviral therapy (0.003). The results also showed that the CT genotype and T allele of the miR-196a2 rs11614913 C>T were associated with decreased risk to COVID-19 with OR=0.76, P=0.006 and OR=0.54, P=0.005, respectively. These results need to be validated with future molecular genetic studies in a larger sample size and different populations.

Keywords: COVID-19 mortality; COVID-19 severity; angiotensin-converting enzyme2; coronavirus infection; coronavirus-19 disease; gene polymorphism; microRNA196a2; pathogenesis; severe acute respiratory syndrome coronavirus-2; susceptibility to SARS-CoV-2.
 
Back
Top Bottom